- Home
- WF vs SNN Comparison
WF vs SNN Comparison
Compare WF & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WF | SNN |
|---|---|---|
| Founded | 1899 | 1856 |
| Country | South Korea | United Kingdom |
| Employees | N/A | 16988 |
| Industry | Commercial Banks | Industrial Specialties |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.5B | 12.7B |
| IPO Year | 2003 | N/A |
Fundamental Metrics
Financial Performance| Metric | WF | SNN |
|---|---|---|
| Price | $72.62 | $30.11 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $36.25 |
| AVG Volume (30 Days) | 136.0K | ★ 1.8M |
| Earning Date | 04-24-2026 | 03-16-2026 |
| Dividend Yield | ★ 3.71% | 2.48% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $18.73 | $8.58 |
| Revenue Next Year | $4.33 | $5.60 |
| P/E Ratio | ★ $9.03 | $64.97 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $48.83 | $28.56 |
| 52 Week High | $84.71 | $38.79 |
Technical Indicators
Market Signals| Indicator | WF | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 66.06 | 42.81 |
| Support Level | $63.03 | $29.21 |
| Resistance Level | $71.30 | $31.18 |
| Average True Range (ATR) | 1.54 | 0.57 |
| MACD | 0.56 | -0.14 |
| Stochastic Oscillator | 93.30 | 6.25 |
Price Performance
Historical ComparisonAbout WF Woori Financial Group Inc. (each representing three (3) shares of)
Woori Financial Group Inc is a banking and financial services holding company that offers a wide range of businesses, including corporate banking, consumer banking, credit card operations, investment banking, capital markets activities, international banking, asset management, life insurance, and other businesses. It provides products and services to customers, which mainly comprise small- and medium-sized enterprises and individuals, as well as some of Korea's corporations. It has six operational business segments: banking, life insurance, credit card, capital, investment securities, and other operations.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.